medigraphic.com
ISSN 0188-2198 (Impreso)

2018, Número 1

Siguiente >>

Rev Mex Cardiol 2018; 29 (1)


Angioplastia carotídea en pacientes diabéticos portadores de estenosis carotídea crítica. Experiencia en un hospital en México; resultados y seguimiento a seis meses

Becerra-Laguna CA, Palacios-Rodríguez JM, García-Gutiérrez JC, García-Bonilla J, Salinas-Aragón MÁ, Córdova-Correa H, López-López HA, Núñez-Blanquet DI

Idioma: Ingles.
Referencias bibliográficas: 30
Paginas: 4-12
Archivo PDF: 234.39 Kb.


RESUMEN

Objetivo: Evaluar el impacto del estado diabético sobre el resultado de los pacientes que se someten a la colocación de stents en la arteria carótida (CAS). Antecedentes: Se ha demostrado que la diabetes es un fuerte predictor de resultados adversos en pacientes sometidos a revascularización coronaria. No se ha determinado su importancia para predecir el resultado de los pacientes que se someten a intervenciones carotídeas. Métodos: Esta investigación es un estudio observacional, retrospectivo, comparativo y descriptivo. Resultados: Se evaluaron 279/341 pacientes/lesiones para la estenosis carotídea sometida a colocación de stents. Se compararon los no diabéticos versus los diabéticos. Del grupo diabético, 59.5% fueron hombres, la mayoría hipertensos y con hipercolesterolemia. Más del 40% de ambos grupos tuvieron una intervención coronaria percutánea (ICP) previa, el 68.2% fueron asintomáticos y la mitad de ellos de alto riesgo, mayor comorbilidad en el grupo diabético con un EuroSCORE › 3, 46 vs 21.4% p = 0.000. No se encontraron diferencias estadísticamente significativas en cuanto a los eventos cardiovasculares adversos mayores (MACE) a los 30 días y acumulados a los seis meses en el grupo no diabético (no DM) versus diabético (DM): nueve pacientes (5.4%) versus ocho (4.8%), p = 0.756 OR; IC 95%: 0.857 (0.322-2.27) y 14 (8.3%) versus nueve (5.3%), p = 0.249 OR; IC 95%: 0.604 (0254-1435), respectivamente. Los pacientes diabéticos tratados con endoprótesis carotídea sometidos a cirugía cardiovascular mostraron una mortalidad intrahospitalaria mayor (4.6 vs 0.6%, p = 0.02). Hubo una mayor tasa de reestenosis (1.9 vs 0%, p = 0.077) en pacientes no diabéticos. Se observó una mayor incidencia de AIT (ataque isquémico transitorio) en pacientes diabéticos (8.7 vs 3.6%, p = 0.05). Conclusión: Los diabéticos que se someten a la CAS son más propensos a tener comorbilidades asociadas. Sin embargo, a pesar de esta desventaja, su resultado a corto plazo después del CAS es similar al de los no diabéticos. El tratamiento endovascular de la estenosis carotídea puede ser una buena alternativa al tratamiento quirúrgico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Biondi-Zoccai GG, Abbate A, Liuzzo G, Biasucci LM. Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol. 2003; 41 (7): 1071-1077.

  2. Gurm HS, Sarembock IJ, Kereiakes DJ, Young JJ, Harrington RA, Kleiman N et al. Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial. J Am Coll Cardiol. 2005; 45 (12): 1932-1938.

  3. Gurm HS, Lincoff AM, Lee D, Tang WH, Jia G, Booth JE et al. Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial. J Am Coll Cardiol. 2004; 43 (4): 542-548.

  4. Weiss JS, Sumpio BE. Review of prevalence and outcome of vascular disease in patients with diabetes mellitus. Eur J Vasc Endovasc Surg. 2006; 31 (2): 143-150.

  5. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med. 2004; 164 (13): 1422-1426.

  6. Stoner MC, Abbott WM, Wong DR, Hua HT, Lamuraglia GM, Kwolek CJ et al. Defining the high-risk patient for carotid endarterectomy: an analysis of the prospective National Surgical Quality Improvement Program database. J Vasc Surg. 2006; 43 (2): 285-295; discussion 295-296.

  7. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004; 351 (15): 1493-1501.

  8. Palacios-Rodríguez JM, Bazzoni-Ruiz A, Torres-Hernández M, Comparán-Núñez A, Ordóñez-Chacón M, Reyes-Dircio S et al. Stent carotídeo en pacientes de alto riesgo: seguimiento a largo plazo. Rev Mex Cardiol. 2004; 15 (1): 5-13.

  9. Kasner SE. Clinical interpretation and use of stroke scales. Lancet Neurol. 2006; 5 (7): 603-612.

  10. North American Symptomatic Carotid Endarterectomy Trial Collaborators, Barnett HJM, Taylor DW, Haynes RB, Sackett DL, Peerless SJ et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991; 325 (7): 445-453.

  11. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke. 2001; 32 (11): 2559-2566.

  12. Göksan B, Erkol G, Bozluolcay M, Ince B. Diabetes as a determinant of high-grade carotid artery stenosis: evaluation of 1,058 cases by Doppler sonography. J Stroke Cerebrovasc Dis. 2001; 10 (6): 252-256.

  13. De Angelis M, Scrucca L, Leandri M, Mincigrucci S, Bistoni S, Bovi M et al. Prevalence of carotid stenosis in type 2 diabetic patients asymptomatic for cerebrovascular disease. Diabetes Nutr Metab. 2003; 16 (1): 48-55.

  14. Lacroix P, Aboyans V, Criqui MH, Bertin F, Bouhamed T, Archambeaud F et al. Type-2 diabetes and carotid stenosis: a proposal for a screening strategy in asymptomatic patients. Vasc Med. 2006; 11 (2): 93-99.

  15. Mostaza JM, González-Juanatey JR, Castillo J, Lahoz C, Fernández-Villaverde JM, Maestro-Saavedra FJ. Prevalence of carotid stenosis and silent myocardial ischemia in asymptomatic subjects with a low ankle-brachial index. J Vasc Surg. 2009; 49 (1): 104-108.

  16. Inzitari D, Eliasziw M, Gates P, Sharpe BL, Chan RK, Meldrum HE et al. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 2000; 342 (23): 1693-1700.

  17. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004; 363 (9420): 1491-1502.

  18. Collins R, Armitage J, Parish S, Sleight P, Peto R; Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004; 363 (9411): 757-767.

  19. Chalmers J, Todd A, Chapman N, Beilin L, Davis S, Donnan G et al. International Society of Hypertension (ISH): statement on blood pressure lowering and stroke prevention. J Hypertens. 2003; 21 (4): 651-663.

  20. Kallikazaros I, Tsioufis C, Sideris S, Stefanadis C, Toutouzas P. Carotid artery disease as a marker for the presence of severe coronary artery disease in patients evaluated for chest pain. Stroke. 1999; 30 (5): 1002-1007.

  21. Asymptomatic Carotid Atherosclerosis Study. Clinical advisory. Carotid endarterectomy for patients with asymptomatic internal carotid artery stenosis. Stroke. 1994; 25: 2523-2524.

  22. Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008; 358 (15): 1572-1579.

  23. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001; 357 (9270): 1729-1737.

  24. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006; 355 (16): 1660-1671.

  25. Ederle J, Dobson J, Featherstone RL, Bonati LH, van der Worp HB, de Borst GJ et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet. 2010; 375 (9719): 985-997.

  26. Fiehler J, Jansen O, Berger J, Eckstein HH, Ringleb PA, Stingele R. Differences in complication rates among the centres in the SPACE study. Neuroradiology. 2008; 50 (12): 1049-1053.

  27. Brott TG, Hobson RW, Howard G, Roubin GS, Clark WM, Brooks W et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010; 363 (1): 11-23.

  28. Economopoulos KP, Sergentanis TN, Tsivgoulis G, Mariolis AD, Stefanadis C. Carotid artery stenting versus carotid endarterectomy: a comprehensive meta-analysis of short-term and long-term outcomes. Stroke. 2011; 42 (3): 687-692.

  29. Brott TG, Howard G, Roubin GS, Meschia JF, Mackey A, Brooks W et al. Long-term results of stenting versus endarterectomy for carotid-artery stenosis. N Engl J Med. 2016; 374 (11): 1021-1031.

  30. Rosenfield K, Matsumura JS, Chaturvedi S. Randomized Trial of Stent Versus Surgery for Asymptomatic Carotid Stenosis. J Vasc Surg. 2016; 64 (2): 536.




2020     |     www.medigraphic.com